Pain Management in Renal Impairment

Initial Treatment

The initial dose of the preferred option for patients with renal impairment should be 0.5-1 mcg/kg IV, and titration should be done carefully based on response, as recommended by the American Society of Health-System Pharmacists 1

The American Geriatrics Society recommends avoiding NSAIDs, including IV ketorolac, in elderly patients with existing renal impairment due to the risk of worsening renal function 2
Acetaminophen is recommended as first-line therapy for noninflammatory pain in CKD patients, starting with standard doses (up to 4g/day) with monitoring, as suggested by the American Journal of Kidney Diseases 3
Certain medications, such as NSAIDs, should be avoided in CKD patients due to their association with worsening kidney function, sodium and water retention, hyperkalemia, and acute kidney injury, as recommended by the American Journal of Kidney Diseases and Arthritis care & research 3, 4
Morphine is contraindicated in patients with renal impairment due to the accumulation of active metabolites, with a strength of evidence level of high, as recommended by the National Comprehensive Cancer Network 5
Fentanyl and buprenorphine are recommended as safer opioid options in patients with chronic kidney disease, particularly those with advanced renal impairment, due to their pharmacological properties and lower risk of accumulation of active metabolites, as suggested by the European Association of Urology and the National Comprehensive Cancer Network 5, 6
Buprenorphine is a suitable option for treating pain in patients with renal impairment due to its pharmacokinetics, according to the National Comprehensive Cancer Network 6

The following opioids are recommended with caution or contraindicated in patients with renal impairment:

Opioid	Recommendation
Fentanyl	Preferred option
Methadone	Use with caution, only by experienced clinicians
Morphine	Contraindicated
Codeine	Avoid use
Meperidine	Contraindicated
Tramadol	Not recommended
Buprenorphine	Safer alternative
Hydromorphone	Safer alternative, start with 25-50% of normal dose
Alfentanil	Safer alternative

Patients with renal impairment should start with reduced doses (25-50% of normal dose) and have their doses titrated carefully based on response and side effects, with extended dosing intervals as necessary, as recommended by the National Comprehensive Cancer Network 7
Standard dosing can be used for pain management, starting at 50-100 mg orally every 4 hours as needed, with maximum daily doses of 500 mg for extended-release or 600 mg for immediate-release formulations, as recommended by the National Comprehensive Cancer Network 6, 7
The National Comprehensive Cancer Network recommends a starting dose of 5 mcg/hour in opioid-naïve patients and a maximum FDA-recommended dose of 20 mcg/hour due to QT prolongation concerns 6
The American College of Cardiology recommends limiting the transdermal dose of buprenorphine to a maximum of 20 mcg/hour due to QT prolongation concerns 6

Patients should be monitored for signs of central nervous system and respiratory depression, and be aware of potential drug interactions, particularly with serotonergic medications (SSRIs, SNRIs, TCAs) due to risk of serotonin syndrome, as cautioned by the National Comprehensive Cancer Network 6, 7
Monitor for respiratory depression, excessive sedation, and constipation in patients on opioids, as recommended by the European Association of Urology 8, 9
Routinely prescribe laxatives for prophylaxis to prevent constipation, as recommended by the American Gastroenterological Association and the American Society of Clinical Oncology 10, 5
Monitor for GI symptoms, renal function, and cardiovascular effects in patients on NSAIDs, as recommended by the European Association of Urology 8

Relaxation techniques, local heat application, and music therapy may be used as non-pharmacological approaches to pain management, as suggested by the Intensive Care Medicine guidelines, European Association of Urology, and Kidney International guidelines 11, 8, 12, 13
Heat or cold therapy can be used for localized pain management in patients on dialysis, as suggested by the American Pain Society 14

Radiographs should be the first imaging modality for acute shoulder pain to rule out fractures, dislocations, or other bony abnormalities, including anterior-posterior views in internal and external rotation and an axillary or scapula-Y view, as recommended by the American College of Radiology 15
MRI without contrast may be considered if radiographs are normal or indeterminate and pain persists, as recommended by the American College of Radiology 15

Common enzyme-linked immunoassay tests used for UDS do not consistently detect hydrocodone, certain benzodiazepines, and their metabolites, which can lead to false-negative results, highlighting the need for more specific testing in CKD patients, as recommended by the American College of Physicians 16
Gas chromatography or mass spectrometry is required to identify specific substances when more accurate detection is needed, as recommended by the American College of Physicians 16

The Infectious Diseases Society of America suggests considering a transitional plan to topical analgesics, such as lidocaine or capsaicin, once oral intake is possible, to optimize pain management 17
Conversion from other opioids to buprenorphine can be complex and may require pain specialty consultation for complex cases, as advised by the National Comprehensive Cancer Network 6
Consider metoclopramide or antidopaminergic drugs to prevent nausea/vomiting, as suggested by the National Comprehensive Cancer Network and the American Gastroenterological Association 10, 5, 18